• Fozia Fatima PEMH Rawalpindi
  • Farzana Hakim Fauji Foundation Medical College
  • Umer Ul Haq PEMH Rawalpindi
  • Muhammad Mehtab Shah PEMH Rawalpindi
  • Fakhara Saba Zeb PEMH Rawalpindi
  • Muhammad Iqbal Qasim Frontier Medical College
  • Shahbaz Ali Khan Ayub Medical College, Abbottabad
  • Amer Fakhar PEMH Rawalpindi
  • Muhammad Adnan Manzar PEMH Rawalpindi



Rheumatoid Arthritis, Cardiovascular risk, QRISK®2, SCORE chart, Statins, Preventive treatment.


Background: The risk of cardiovascular disease in patients with inflammatory joint diseases is very high and rheumatologists need to screen their patients for this risk. A number of screening tools have been used in this patient population. Objective was to compare the cardiovascular risk assessment in patients with inflammatory joint diseases using QRISK®2 and Reynolds Risk Score. Methods: Four hundred and one patients with inflammatory joint diseases were enrolled via consecutive non-probability sampling. Their future cardiovascular disease risk was calculated via the QRISK®2 and Reynolds Risk Scores. The resulting scores were analyzed for any correlation. Results: There was no significant correlation between the scores obtain via both risk assessment tools (p>0.05).


Makavos G, Varoudi M, Papangelopoulou K, Kapniari E, Plotas P, Ikonomidis I, et al. Echocardiography in Autoimmune Rheumatic Diseases for Diagnosis and Prognosis of Cardiovascular Complications. Med Kaunas Lith. 2020;56(9):E445.

Symmons DPM, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol. 2011 May 31;7(7):399–408.

Villa-Forte A, Mandell BF. [Cardiovascular disorders and rheumatic disease]. Rev Esp Cardiol. 2011 Sep;64(9):809–17.

Owlia MB, Mostafavi Pour Manshadi SMY, Naderi N. Cardiac manifestations of rheumatological conditions: a narrative review. ISRN Rheumatol. 2012;2012:463620.

Sharma A, Christodorescu R, Agbariah A, Duda-Seiman D, Dahdal D, Man D, et al. Cardiovascular Risk Prediction Parameters for Better Management in Rheumatic Diseases. Healthcare. 2022 Feb 7;10(2):312.

Popa M-D, Sharma A, Kundnani NR, Gag OL, Rosca CI, Mocanu V, et al. Identification of Heavy Tobacco Smoking Predictors-Influence of Marijuana Consuming Peers and Truancy among College Students. Healthcare. 2021 Dec 1;9(12):1666.

Buleu F, Sirbu E, Caraba A, Dragan S. Heart Involvement in Inflammatory Rheumatic Diseases: A Systematic Literature Review. Medicina (Mex). 2019 Jun 6;55(6):249.

Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol. 2015 Dec;11(12):693–704.

Atzeni F, Nucera V, Gerratana E, Fiorenza A, Gianturco L, Corda M, et al. Cardiovascular Consequences of Autoimmune Rheumatic Diseases. Curr Vasc Pharmacol. 2020 Sep 17;18(6):566–79.

Prasad M, Hermann J, Gabriel SE, Weyand CM, Mulvagh S, Mankad R, et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol. 2015 Mar;12(3):168–76.

Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 2002 Apr;46(4):862–73.

Chen Y-J, Liu S-C, Lai K-L, Tang K-T, Lin C-H, Chen Y-M, et al. Factors associated with risk of major adverse cardiovascular events in patients with rheumatoid arthritis: a nationwide, population-based, case-control study. Ther Adv Musculoskelet Dis. 2021;13:1759720X2110308.

Castañeda S, Nurmohamed MT, González-Gay MA. Cardiovascular disease in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol. 2016;30(5):851–69.

Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71(9):1524–9.

Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJL, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017 Jan;76(1):17–28.

Cardiovascular Risk Score (QRISK2) [Internet]. Silverdale & Rycroft Practice. 2022 [cited 2022 Apr 9]. Available from:

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486–97.

Ridker PM, Buring JE, Rifai N, Cook NR. Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score. JAMA. 2007 Feb 14;297(6):611.

López-Mejías R, Castañeda S, González-Juanatey C, Corrales A, Ferraz-Amaro I, Genre F, et al. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers. Autoimmun Rev. 2016 Nov;15(11):1013–30.

Amaya-Amaya J, Montoya-Sánchez L, Rojas-Villarraga A. Cardiovascular Involvement in Autoimmune Diseases. BioMed Res Int. 2014;2014:1–31.

Gasparyan AY, Ayvazyan L, Cocco G, Kitas GD. Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research. Curr Pharm Des. 2012;18(11):1543–55.

Bartoloni E, Alunno A, Bistoni O, Gerli R. Cardiovascular Risk in Rheumatoid Arthritis and Systemic Autoimmune Rheumatic Disorders: a Suggested Model of Preventive Strategy. Clin Rev Allergy Immunol. 2013 Feb;44(1):14–22.

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016 Aug 1;37(29):2315–81.

Arts EEA, Popa C, Den Broeder AA, Semb AG, Toms T, Kitas GD, et al. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis. 2015 Apr;74(4):668–74.

Arts EEA, Popa CD, Den Broeder AA, Donders R, Sandoo A, Toms T, et al. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. Ann Rheum Dis. 2016 Apr;75(4):674–80.



Most read articles by the same author(s)